Stuart Seropian

1.7k total citations · 1 hit paper
26 papers, 761 citations indexed

About

Stuart Seropian is a scholar working on Oncology, Epidemiology and Hematology. According to data from OpenAlex, Stuart Seropian has authored 26 papers receiving a total of 761 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Epidemiology and 9 papers in Hematology. Recurrent topics in Stuart Seropian's work include Immune Cell Function and Interaction (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Influenza Virus Research Studies (3 papers). Stuart Seropian is often cited by papers focused on Immune Cell Function and Interaction (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Influenza Virus Research Studies (3 papers). Stuart Seropian collaborates with scholars based in United States. Stuart Seropian's co-authors include Dennis Cooper, Matthew P. Strout, Nancy Berliner, Jenni Bloomquist, Andrew St. Martin, Marcie Riches, Amer M. Zeidan, Lohith Gowda, Muhammad Bilal Abid and Jean L. Bolognia and has published in prestigious journals such as Blood, Hepatology and Journal of the American Academy of Dermatology.

In The Last Decade

Stuart Seropian

26 papers receiving 751 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study

2021 202 citations Akshay Sharma, Neel S. Bhatt et al. The Lancet Haematology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stuart Seropian United States	13	342	297	255	190	107	26	761
Birte Wistinghausen United States	11	266 0.8×	293 1.0×	172 0.7×	291 1.5×	118 1.1×	29	705
J. A. Gastaut France	18	336 1.0×	232 0.8×	199 0.8×	271 1.4×	202 1.9×	40	937
Ryan DeMasi United States	14	387 1.1×	236 0.8×	97 0.4×	226 1.2×	137 1.3×	30	1.1k
José Francisco Tomás Spain	17	455 1.3×	173 0.6×	145 0.6×	120 0.6×	200 1.9×	47	944
Ioannis Mantzaris United States	12	182 0.5×	363 1.2×	248 1.0×	149 0.8×	40 0.4×	70	812
Riad El Fakih Saudi Arabia	13	275 0.8×	218 0.7×	122 0.5×	87 0.5×	84 0.8×	76	672
H. Einsele Germany	13	321 0.9×	344 1.2×	155 0.6×	120 0.6×	343 3.2×	22	782
Janet Poole South Africa	14	251 0.7×	153 0.5×	120 0.5×	133 0.7×	83 0.8×	29	612
J.A. Gastaut France	16	514 1.5×	287 1.0×	251 1.0×	190 1.0×	239 2.2×	38	1.1k
Manuel Abecasis Portugal	11	488 1.4×	220 0.7×	180 0.7×	198 1.0×	230 2.1×	24	865

Countries citing papers authored by Stuart Seropian

Since Specialization

Citations

This map shows the geographic impact of Stuart Seropian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Seropian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Seropian more than expected).

Fields of papers citing papers by Stuart Seropian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart Seropian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Seropian. The network helps show where Stuart Seropian may publish in the future.

Co-authorship network of co-authors of Stuart Seropian

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart Seropian. A scholar is included among the top collaborators of Stuart Seropian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart Seropian. Stuart Seropian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sharma, Akshay, Neel S. Bhatt, Andrew St. Martin, et al.. (2021). Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study. The Lancet Haematology. 8(3). e185–e193. 202 indexed citations breakdown →

Branagan, Andrew R., Eamon Duffy, Geliang Gan, et al.. (2021). Tandem high-dose influenza vaccination is associated with more durable serologic immunity in patients with plasma cell dyscrasias. Blood Advances. 5(5). 1535–1539. 13 indexed citations

Zhou, Bin, Jane Dixon, Ruth McCorkle, et al.. (2020). Cardiotoxicity in Hematopoietic Stem Cell Transplant: Keeping the Beat. Clinical Lymphoma Myeloma & Leukemia. 20(4). 244–251.e4. 10 indexed citations

McManus, Dayna, Noffar Bar, Francine M. Foss, et al.. (2019). The impact of a multimodal approach to vancomycin discontinuation in hematopoietic stem cell transplant recipients (HSCT) with febrile neutropenia (FN). Transplant Infectious Disease. 21(2). e13059–e13059. 5 indexed citations

Branagan, Andrew R., Eamon Duffy, Randy A. Albrecht, et al.. (2017). Clinical and Serologic Responses After a Two-dose Series of High-dose Influenza Vaccine in Plasma Cell Disorders: A Prospective, Single-arm Trial. Clinical Lymphoma Myeloma & Leukemia. 17(5). 296–304.e2. 35 indexed citations

Foss, Francine, et al.. (2016). Infusion reactions are common after high-dose carmustine in BEAM chemotherapy and are not reduced by lengthening the time of administration. Supportive Care in Cancer. 25(1). 205–208. 1 indexed citations

Hur, David J., Steffen Huber, Hamid Mojibian, et al.. (2016). Serial Native T1 Mapping to Monitor Cardiac Response to Treatment in Light-Chain Amyloidosis. Circulation Cardiovascular Imaging. 9(10). 15 indexed citations

Cecchini, Michael, Mario Sznol, & Stuart Seropian. (2015). Immune therapy of metastatic melanoma developing after allogeneic bone marrow transplant. Journal for ImmunoTherapy of Cancer. 3(1). 10–10. 5 indexed citations

Sehgal, Kartik, Rituparna Das, Lin Zhang, et al.. (2015). Clinical and pharmacodynamic analysis of pomalidomide dosing strategies in myeloma: impact of immune activation and cereblon targets. Blood. 125(26). 4042–4051. 91 indexed citations

10.

Branagan, Andrew R., Eamon Duffy, Randy A. Albrecht, et al.. (2015). Fluzone® High-Dose Influenza Vaccine with a Booster Is Associated with Low Rates of Influenza Infection in Patients with Plasma Cell Disorders. Blood. 126(23). 3058–3058. 1 indexed citations

11.

Seropian, Stuart, et al.. (2013). Monitoring patient distress and related problems before and after hematopoietic stem cell transplantation. Palliative & Supportive Care. 12(1). 53–61. 9 indexed citations

12.

Parker, Terri L., Dennis Cooper, Stuart Seropian, & Jean L. Bolognia. (2012). Toxic erythema of chemotherapy following i.v. BU plus fludarabine for allogeneic PBSC transplant. Bone Marrow Transplantation. 48(5). 646–650. 11 indexed citations

13.

Strout, Matthew P., Stuart Seropian, & Nancy Berliner. (2010). Alemtuzumab as a bridge to allogeneic SCT in atypical hemophagocytic lymphohistiocytosis. Nature Reviews Clinical Oncology. 7(7). 415–420. 60 indexed citations

14.

Schaffer, Julie V., Jennifer M. McNiff, Stuart Seropian, Dennis Cooper, & Jean L. Bolognia. (2005). Lichen sclerosus and eosinophilic fasciitis as manifestations of chronic graft-versus-host disease: Expanding the sclerodermoid spectrum. Journal of the American Academy of Dermatology. 53(4). 591–601. 49 indexed citations

15.

Seropian, Stuart, Erkut Bahceci, & Dennis Cooper. (2003). Allogeneic peripheral blood stem cell transplantation for high-risk non-Hodgkin's lymphoma. Bone Marrow Transplantation. 32(8). 763–769. 13 indexed citations

16.

Strasser, Simone I., Howard M. Shulman, Mary E.D. Flowers, et al.. (2000). Chronic Graft–Versus–Host Disease of the Liver: Presentation As An Acute Hepatitis. Hepatology. 32(6). 1265–1271. 74 indexed citations

17.

Seropian, Stuart, et al.. (1999). Use of rituximab and irradiated donor-derived lymphocytes to control Epstein–Barr virus-associated lymphoproliferation in patients undergoing related haplo-identical stem cell transplantation. Bone Marrow Transplantation. 24(11). 1253–1258. 30 indexed citations

18.

Seropian, Stuart, et al.. (1999). Neutropenic infections in 100 patients with non-Hodgkin’s lymphoma or Hodgkin’s disease treated with high-dose BEAM chemotherapy and peripheral blood progenitor cell transplant: out-patient treatment is a viable option. Bone Marrow Transplantation. 23(6). 599–605. 37 indexed citations

19.

Seropian, Stuart, et al.. (1998). Lack of reactivity to CMV pp65 antigenemia testing in a patient with CMV disease following allogeneic bone marrow transplant. Bone Marrow Transplantation. 22(5). 507–509. 12 indexed citations

20.

Seropian, Stuart, et al.. (1998). HLA-mismatched family donor transplants: a novel strategy as curative therapy for patients with hematologic disorders.. PubMed. 4(5). 278–86. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact